Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAIR: FFR-guided Renal Stenting vs Sham
NCT07111442Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Aug 2025
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
Randomised, double-blind trial (3 arms), sponsored by Peking University First Hospital. Primary endpoint: Percentage reduction in daytime mean systolic blood pressure measured by ambulatory blood pressure monitoring at 3 months. Planned start Aug 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07111442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07111442.